Document is current
Any future updates will be listed below
-
Authors
Lobentanzer, Sebastian https://orcid.org/0000-0003-3399-6695
Rodriguez-Mier, Pablo https://orcid.org/0000-0002-4938-4418
Bauer, Stefan https://orcid.org/0000-0003-1712-060X
Saez-Rodriguez, Julio https://orcid.org/0000-0002-8552-8976
-
Funding
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (951773)
EC | Horizon 2020 Framework Programme (965193)
- License Information
-
More Information
Article History
Received: 17 January 2024
Revised: 18 March 2024
Accepted: 21 March 2024
First Online: 18 June 2024
Disclosure and competing interests statement
: SL, PRM, and SB declare no competing interests. JSR reports funding from GSK, Pfizer, and Sanofi and fees/honoraria from Travere Therapeutics, Stadapharm, Astex, Pfizer, Owkin, and Grunenthal.
